Myasthenia gravis: open trials in Israel

• NCT05374590

  Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

  Trial Treatment · Phase 2/3 · argenx

  Hadassah Medical Center - Ein Kerem, Jerusalem

  Registry updated 2026-11-03

• NCT07217587

  Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis

  Trial Treatment · Phase 3 · Janssen Research & Development, LLC

  Rambam Medical Center, Haifa · Sourasky Medical Center, Tel Aviv

  Registry updated 2026-11-03

• NCT06392386

  A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

  Trial Treatment · Phase 2/3 · argenx

  Hadassah Medical Center - Ein Kerem, Jerusalem · Schneider Children's Medical Center of Israel, Petah Tikvah · Tel Aviv Sourasky Medical Center Ichilov, Tel Aviv

  Registry updated 2026-09-28

• NCT07085676

  Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases

  Trial Treatment · Phase 1 · Polina Stepensky

  Hadassah MO, Jerusalem

  Registry updated 2026-05-06

• NCT06688253

  Intravenous Human IgG1 Fc Fragment (Efgartigimod) in Myasthenic Crisis

  Trial Treatment · Phase 4 · Rambam Health Care Campus

  Rambam- Department of Neurology, Haifa

  Registry updated 2024-11-14

All Myasthenia gravis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error